Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1985 Oct 12;291(6501):1015–1016. doi: 10.1136/bmj.291.6501.1015

Rheumatoid factors and amyloidosis in rheumatoid arthritis.

C P Maury, A M Teppo
PMCID: PMC1416925  PMID: 3931772

Full text

PDF
1016

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dixon J. S., Pickup M. E., Lowe J. R., Hallett C., Lee M. R., Wright V. Discriminatory indices of response of patients with rheumatoid arthritis treated with D-penicillamine. Ann Rheum Dis. 1980 Aug;39(4):301–311. doi: 10.1136/ard.39.4.301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Häyry P., von Willebrand E., Taskinen E., Höckerstedt K., Ahonen J., Eklund B. Is uremia immunosuppressive in renal transplantation? Transplantation. 1982 Nov;34(5):268–272. doi: 10.1097/00007890-198211000-00006. [DOI] [PubMed] [Google Scholar]
  3. Masi A. T., Maldonado-Cocco J. A., Kaplan S. B., Feigenbaum S. L., Chandler R. W. Prospective study of the early course of rheumatoid arthritis in young adults: comparison of patients with and without rheumatoid factor positivity at entry and identification of variables correlating with outcome. Semin Arthritis Rheum. 1976 May;4(4):299–326. doi: 10.1016/0049-0172(76)90013-5. [DOI] [PubMed] [Google Scholar]
  4. Maury C. P. Reactive (secondary) amyloidosis and its pathogenesis. Rheumatol Int. 1984;5(1):1–7. doi: 10.1007/BF00541358. [DOI] [PubMed] [Google Scholar]
  5. Wernick R., Merryman P., Jaffe I., Ziff M. IgG and IgM rheumatoid factors in rheumatoid arthritis. Quantitative response to penicillamine therapy and relationship to disease activity. Arthritis Rheum. 1983 May;26(5):593–598. doi: 10.1002/art.1780260503. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES